COMMUNIQUÉS West-GlobeNewswire

AMAG Pharmaceuticals Enters Into Definitive Merger Agreement to Acquire Perosphere Pharmaceuticals

13/12/2018 - 12:30

Next Generation Anticoagulant Reversal Agent, Ciraparantag, Will Add Innovative Clinical Stage Asset to AMAG’s Hematology Portfolio Conference call scheduled for 8:00 a.m. ET today WALTHAM, Mass., Dec. 13, 2018 (GLOBE [...]

Les résultats de l’étude de phase 2 visant à traiter la dermatite atopique réalisée par XBiotech semblent indiquer un nouveau traitement pour la maladie dermatologique

13/12/2018 - 12:17

Le traitement par bermekimab réduit de manière rapide et significative la maladie. AUSTIN, Texas, 13 déc. 2018 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ : XBIT) a annoncé aujourd’hui la conclusion de l’étude ouverte [...]

Meetings Held With FDA Support Mesoblast’s Planned Regulatory Filing for Commercialization of Remestemcel-L in Acute GVHD

13/12/2018 - 12:00

NEW YORK and MELBOURNE, Australia, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that recent meetings held with the United States Food and Drug Administration (FDA) support [...]

Ossur Hf : Financial calendar 2019

13/12/2018 - 10:57

Announcement no. 71/2018 13 December 2018 Össur's financial calendar 2019 Interim Report Q4 2018 and Annual Report for 2018 5 February 2019 Annual General Meeting 7 March 2019 Interim Report Q1 2019 30 April 2019 [...]

IMV Inc. Presents Updated Positive Data From Phase 1b/2 Combination Clinical Trial in Advanced Ovarian Cancer at 2018 ESMO Immuno-Oncology Congress

13/12/2018 - 10:05

73% of tumor regressions and 80% of clinical responses were observed in a subpopulation defined by a clinical biomarker based on Baseline Tumor Burden All durable clinical responses continued beyond the one year of [...]

Curetis Sharpens Focus on Near-Term Strategic Value Drivers

13/12/2018 - 09:04

Business focus on U.S. commercialization, strategic partnering, Ares Genetics and asset monetization Reduction of net cash consumption by up to 50% (YoY) expected Amsterdam, the Netherlands, Holzgerlingen, Germany, and [...]

PledPharma presents results from study on drug candidate Aladote® for paracetamol poisoning at a global toxicology conference

13/12/2018 - 08:00

Stockholm, December 13, 2018. PledPharma AB (publ) announces that the company's Aladote ® Phase Ib/IIa study results has been accepted for a poster presentation during the “58th Annual Meeting of the Society of [...]

Rule 2.9 Announcement

13/12/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 13 December 2018 [...]

Saniona AB’s Nomination Committee for the Annual General Meeting 2019

13/12/2018 - 08:00

PRESS RELEASE December 13, 2018 The Annual General Meeting on May 24, 2018, resolved that a Nomination Committee shall be appointed before coming election and remuneration. The Nomination Committee shall comprise three [...]

Novartis receives European Commission approval for self-administration of Xolair® across all indications

13/12/2018 - 07:16

The EC approval underscores the long-term safety and efficacy of Xolair demonstrated in clinical studies and by 13 years of real-world use in Europe[1] Xolair ® (omalizumab) prefilled syringe (PFS) is the first and only [...]

Marinus Pharmaceuticals Announces Pricing of Public Offering of Common Stock

13/12/2018 - 02:26

RADNOR, Pa., Dec. 12, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) (“Marinus” or the “Company”) announced the pricing of an underwritten public offering of 12,000,000 shares of common stock at a [...]

Zynerba Pharmaceuticals Announces Sustained Improvements in Emotional and Behavioral Symptoms of Fragile X Syndrome through 12 Months of Treatment with ZYN002

12/12/2018 - 23:30

- Patients Experienced a 77% Improvement in Aberrant Behaviors Associated with Social Avoidance Compared to Baseline after One Year of ZYN002 Treatment - - Presentation Today at the 57th Annual Meeting of the American [...]

Synthorx Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

12/12/2018 - 22:05

SAN DIEGO, Dec. 12, 2018 (GLOBE NEWSWIRE) -- Synthorx, Inc. (Nasdaq: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop optimized biologics for [...]

Idera Pharmaceuticals to Provide ILLUMINATE-204 Clinical Data Update on Friday, December 14, 2018

12/12/2018 - 22:01

EXTON, Pa., Dec. 12, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical-stage biopharmaceutical company focused on the development and ultimate commercialization of drug candidates for both [...]

AGTC Announces Topline Interim Six-Month Data from Phase 1/2 X-Linked Retinoschisis Clinical Study; Termination of Biogen Collaboration

12/12/2018 - 22:01

- Results from XLRS study support general safety and tolerability of AGTC’s gene delivery platform but did not demonstrate signs of clinical activity at interim six-month time point - - AGTC to regain rights to five [...]

VBI Vaccines Announces Proposed Public Offering of Common Shares

12/12/2018 - 22:01

CAMBRIDGE, Mass., Dec. 12, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today [...]

Improved Accuracy and Speed for Disease Research, Two Genomic Companies Integrate Kits and Software to Enable Deep Exploration of Epigenetic Data

12/12/2018 - 21:16

OnRamp’s ROSALIND and Active Motif offer an improved ChIP-Seq data analysis experience for researchers with state-of-the-art dynamics track plots and advanced collaboration capabilities SAN DIEGO, Dec. 12, 2018 (GLOBE [...]

Alkaline Water: A Well-Known Brand Enters the CBD Space -- CFN Media

12/12/2018 - 19:46

SEATTLE, Dec. 12, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering [...]

Advanzeon Solutions, Inc.’s Wholly-Owned Subsidiary Pharmacy Value Management Solutions, Inc. Announces Medical Director and Members of Its Medical Advisory Board Voted Top Doctors by Peers

12/12/2018 - 18:06

TAMPA, Fla., Dec. 12, 2018 (GLOBE NEWSWIRE) -- Advanzeon Solutions, Inc.’s (OTCBB:CHCR) ("Advanzeon") wholly-owned subsidiary, Pharmacy Value Management Solutions, Inc. ("PVMS") (collectively, the "Company"), announced [...]